The World Health Organization (WHO) is the only organization that the world is depending on, during this pandemic. With the following statements from WHO, it clears ambiguity to alleviate fears. The recent statement from WHO, however, explained that asymptomatic coronavirus transmission is not common.
Looking at the figures worldwide show, a significant number of people are tested positive for the deadly virus. However, it is assumed that not all of them pass on their infections majorly. However, although rare, it does not rule out the transmission of the virus before the development of symptoms.
Analysis of coronavirus transmission by WHO
Dr. Maria Van Kerkhove is the head of emerging diseases at WHO. She also had a Q/A session on COVID-19 in March, posted on YouTube, and available here.
She has commented about the asymptomatic transmission saying that it is based on the evidence received. The countries executed comprehensive contact tracing, to give concrete evidence. She further made a clear distinction of 3 separate categories, while analyzing the coronavirus.
- Infected patients who have not experienced any symptoms (asymptomatic)
- Infected patients testing positive for the virus despite no prior experience of any symptoms. However, they have now begun developing them (pre-symptomatic)
- Infected patients who are experiencing very light or atypical symptoms. Hence, they are unaware that they have the coronavirus.
She explained that few reports differentiate between these categories, unlike others. In addition to the study of other small groups, the conclusions are difficult to come across. However, based on the cumulative evidence, Dr. Van Kerkhove confirmed the “insignificant” risk of asymptomatic transmission.
WHO recently explained the importance of face masks and the percentage of reduction in transmission. The statement suggested the above argument.
In England, the Office for National Statistics (ONS) has continued to examine a unit of the population regularly. According to the reports, out of all infected coronavirus patients tested positive, 29% reported symptoms. This was during the testing, or prior to the testing with the inclusion of visits.
The contact tracing from several countries is the foundation for the collected evidence. Prof Babak Javid, an infectious diseases consultant at the Unversity of Cambridge explained the transmission. It suggests that asymptomatic transmission exits. However, it is rare. He continued that infection transmission usually happens after the development of symptoms. This could be the initial stage or when they are very mild.
Identifiable amounts of the virus can exist in patients approximately 3 days prior to the development of symptoms. At this stage, transmission can take place, especially during the first signs of first symptoms.
Asymptomatic people are further unaware of them being contagious. However, Prof Javid explained that pre-symptomatic people had to follow a few guidelines. This included tracking, tracing, and self-isolation rules.
Prof Liam Smeeth, an epidemiologist at the London School of Hygiene and Tropical Medicine also added to this matter. H explained that this reflects the importance of lockdown measures and how it has reduced the spread significantly.
Asymptomatic people could be capable of transmitting the virus. However, the possibility is extremely rare, suggests by the current evidence. Hence, it holds pre-symptomatic people at the highest risk.
A positive test does not determine the amount of virus in a person’s body. This is called the viral load. Furthermore, the method of contact can highly determine the likeliness of the infection. Hence, contact tracing is important for the determination of the transmission of the virus. Dr. Van Kerkhove pointed out the “injection droplets” that are the biggest threat in transmission. Furthermore, the most significant amount of infection droplets are passed on during coughing and sneezing. This consequently increases the rate of transmission.
Study Opens Gateway For Using Marijuana For Treatment Of PTSD
As the cannabis industry is evolving and generating large-profits, scientists and researchers are also focusing on discovering more about marijuana. Moreover, researchers aim to find better treatment possibilities, dose adjustments, and products that can help individuals. A recent study suggests marijuana can help treat PTSD, reports Forbes.
However, the study is under process and has been approved by FDA, for phase 2 trials. Sue Sisley, MD, discussed her study goals and discoveries in a symposium for marijuana, internist, and telemedicine. Her study aims to use marijuana to treat people who suffer from PTSD disorder.
Other researchers, research institutions, and companies are also working on similar projects. The Battle Brothers Foundation also gets approval for researching the use of cannabis to combat PTSD in veterans. Moreover, there is an urgent need to treat PTSD in veterans as the suicide rate due to post-traumatic stress disorder is getting higher.
Sisley Cannabis Research For PTSD treatment
Sue Sisley was for many years an anti-marijuana. However, her perspective regarding cannabis changed when she was treating veterans. While she was treating them, she discovered that the veteran community uses higher doses of marijuana. Moreover, overdoses of the drug occur in them, and they start using addictive medications.
For her study, the University of Colorado gave $2.15 million in funds. Moreover, the study subject is one of a kind and will enable marijuana-use to treat PTSD. She was able to get approval for phase 2 trials after seven years of hard work. Sixty veterans were part of the research trials. They were given 12 percent THC and 12 percent CBD for treatment.
Individuals show improvement in symptoms and overall condition. The study monitors biomarkers for inflammation, DSM-5, objective sleep measurement, and Inventory of Depression and Anxiety Symptoms.
Battle Brothers Foundation Research
The Battle Brothers Foundation is working with NiaMedic to determine marijuana use for treating PTSD. Furthermore, the national Independent Review Board is an independent committee that allows both groups to perform the research project.
To determine the effects of marijuana on treating psychotic disorders, the researchers will enroll 60 California veterans. Individuals will also receive limited cannabis doses for treatment of post-traumatic stress disorder.
According to Bryan Buckley, 22 veterans are dying due to the effects of post-traumatic stress. Moreover, they become addicted to opioids.
Cases of post-traumatic stress disorder in U.S. troops have increased remarkably in the last 13 years. It is the need of the hour to research and formulate better techniques for improving the condition of individuals suffering from PTSD.
Moreover, the veterans that have been offering services in Afghanistan and Iraq suffer from a psychotic disorder. Data analysis will occur in the presence of medical doctors and experts.
Marijuana Use And PTSD
Individuals have been given cannabis edible products for medical use. The controlled drug is psychoactive that elevates mood, makes individuals relax, and generates a feeling of pleasure.
Individuals that have been through immense trauma, stress, and pain are more likely to develop post-traumatic stress disorder. Moreover, individuals that experience or witness any natural disaster, an accident, a terrorist’s act, war or rape, death threats, and sexual violence are likely to suffer PTSD. Marijuana can provide a solution to the problem and symptoms of post-traumatic stress disorder.
The research subject will open a new field for use of cannabis and improves the condition of marijuana. However, completion of research requires some time, and to obtain large-scale research results research on a wider scale needs to occur.
The efforts of Sue and the Battle Brothers Foundation will yield a positive outcome separately. Moreover, it will provide hope to individuals suffering from post-traumatic-stress-disorder.
Cannabis Industry, Celiac Disease, And Processed Flour
The cannabis industry shall learn from the errors of the flour and cheese industry. Use of certain products, including bleached-flour and consumption of mass gluten, causes multiple diseases, including celiac disease. Due to this reason, many countries around the world including the U.K. and China restrict the use of mass-gluten in the production of flour and cheese.
However, the North American Flour Industry uses two restricted bleaching agents, namely calcium peroxide and benzoyl. Moreover, they use these bleaching agents in the formulation of flour. The possibly damaging point is that these bleaching agents lead to the development of autoimmune diseases and celiac.
The cannabis industry must solve and prepare beforehand for various problems to continue evolving. Moreover, the marijuana industry has been under suppression for a longer duration. Thus, it must take every step considering the consequences and make efforts to evolve.
Vape pen formulation also causes oxidation issues similar to the flour-industry. So, the cannabis industry needs to modify formulation formulas and techniques to produce products that do not lead to diseases. Moreover, there are chances that these diseases can lead individuals to death. Thus, there is also an immediate need to cut off ingredients from processed foods, flour, and other products that can cause cancer or other autoimmune diseases.
What Is Celiac Disease?
Celiac disease is an autoimmune disease and is a genetic disease. People with the genetic-disease may or may not have symptoms. However, people with asymptomatic celiac disease can develop symptoms later in life.
Furthermore, the risk of developing celiac disease increases due to various factors, including excessive gluten consumption and eating a lot of processed foods. The main ingredient causing autoimmune-disease is benzoyl peroxide, as it affects flesh and gut bacteria.
Moreover, benzyl peroxide irritates the skin, causes an antibiotic response, and generates free radicles. Overall, it damages the body and causes the development of autoimmune diseases and cancer. The cannabis vape pens also change color after some time, and oxidation of its agents causes an alteration in its formula leading to pathological conditions.
Excessive Gluten Consumption And Cannabis
Cannabis industrialists must not use ingredients that can damage the body organs or cause any disease. Moreover, the industry shall avoid using ingredients that it uses to prevent the decolorization of vape pens. Moreover, such chemicals are capable of increasing the risk of autoimmune diseases like celiac disease.
Individuals with celiac disease have high amounts of enzyme elastase. Gluten breakdown occurs in the presence of enzyme elastase. After breaking, it converts to an amino acid and is considered by the body as toxins. The body begins to fight itself, leading to the initiation of autoimmune diseases like celiac disease.
Excessive gluten consumption results in a large amount of amino acid production. Moreover, the body considers the amino acid as a toxin and starts to fight the cells containing it, leading the body to fight its cells. Furthermore, mass gluten consumption causes microbiome disruption and strips away the microbiome barrier.
Benzyl Peroxide And Other Food Alterations
In addition to gluten, benzoyl peroxide and other such agents in processed flour and cannabis products can have a peeling impact. The bleaching agents erode intestinal-lining, leading to breakage of the wall and damaging the digestive and immune system.
Food is changing genetically, and alterations in the soil are also occurring at a faster rate. Moreover, genetic alterations in the plant seeds cause other beneficial effects, but few are life-threatening.
Furthermore, cannabis cultivation and production need new modified methods for maintaining a variety of marijuana. Over the coming years, how the food industry and crop cultivation changes for the better are yet unclear. However, researchers need to formulate better techniques for future healthy varieties of food and crops.
Mayor To Cut the Ribbon on Cannabis ‘Cookies’ Inauguration
Michigan is seeing an increase in activities and businesses trading in marijuana. As the marijuana economy grows, Cookies is the newest store that opens its doors to Kalamazoo city. The Cookies cannabis store will be functional from Friday, Feb. 26, reports Mlive.
The mayor for the city of Kalamazoo, David Anderson, is the chief guest for the ribbon-cutting ceremony. The store opening will be in the morning, according to the Cookies Cannabis Official press release. Also, the address for the store is 2712 Portage Street.
Medicinal Cannabis At The Curbside
The Cannabis Cookies store will not be offering curbside sales on its first day. For medicinal marijuana sales, curbside medical sales will be active from Saturday, Feb. 27, the press release further adds.
Cookies is an international cannabis lifestyle brand founded by California rapper and entrepreneur, Berner.
Cookies CEO Berner has high hopes for the Midwest. He thinks that stores like his will boost the marijuana economy and can support the economy even during slumps. Cookies has pinpointed the region as pivotal going forwards. The partnership with Gage Cannabis is also proving great for them as the demand for cannabis and medical marijuana is increasing day by day.
The expansion is driven by key partnerships and a high influx of consumers. Consumers are not only driving up demand in Kalamazoo but in the whole of Michigan. Cookies hopes to serve this rising demand as it strikes new partnerships throughout the region.
Cannabis2 years ago
How CBD oil works?
Cannabis2 years ago
Research Suggests Cannabis Effective in Treating Endometriosis
Health1 year ago
Diabetes Freedom Review – A Natural Way To Beat Diabetes Type 2
Cannabis2 years ago
CBD Gummies: How does it work? Benefits, Pricing and Packages
Health2 years ago
VitaMove, a Popular Formula to Relieve Back Pain is Restocked
Featured2 years ago
Prosper Wellness TurmeriCBD Review – A combination of Turmeric and CBD?
Cannabis2 years ago
What are the main advantages of consuming CBD oil?
Cannabis2 years ago
Can Cannabis Survive in Pharma?